Jennifer Leonard

Mimecast Outlook MailChimp SPF Microsoft Office 365 Google Cloud Hosting Drupal Adobe Marketing Cloud iCIMS Remote

ophthalmology glaucoma wetamd optometry eye disease retinal disease biotechnology life sciences biotechnology: laboratory analytical instruments industrials biotechnology research sustained release durasert technology verisome technology vorolanib eyp-1901 intravitreal injection wet amd diabetic macular edema non-proliferative diabetic retinopathy clinical trials drug delivery bioerodible matrix sustained drug delivery systems anti-vegf treatment therapeutics development drug formulations patient safety regulatory compliance biopharmaceuticals ocular disorders fda approval investigational drugs patient recruitment clinical trial phases vision improvement therapeutic efficacy innovative solutions ocular drug delivery pharmaceutical manufacturing market access biologic agents ophthalmic products pharmacopeia patient-centered care long-acting therapies treatment regimens drug compounds vision health retina specialists scientific publications medical ethics biotechnology partnerships investor relations pharmaceutical technology market trends product pipeline clinical-stage ophthalmic therapies retinal diseases sustained-release drug delivery innovative therapeutics durasert e™ technology dexycu wet age-related macular degeneration patient-centric innovation healthcare professionals strategic partnerships research & development ocular surgery patient outcomes chronic eye conditions advanced drug delivery systems pharmaceutical industry patient compliance unmet medical needs quality of life compassionate care collaboration integrity market position geographic reach healthcare stakeholders drug delivery technology investor engagement vision preservation health care health wellness & fitness hospital & health care pharmaceuticals medical